Gene therapy of focal cerebral ischemia using defective recombinant adeno-associated virus vectors

Frontiers in Bioscience

Volumn 11, Issue SUPPL. 1, 2006, Pages 2061-2070

  Tsai, Tung Han ^a   Chen, Show Li ^b   Xiao, Xiao ^c   Chiang, Yung Hsiao ^a   Tsao, Yeou Ping ^d  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Adeno associated virus; Adenovirus; Apoptosis; Brain; Cytokine; GDNF; IL 1Ra; Neruron; Nervous system; Rat; Review; Stroke

Indexed keywords

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; MURINAE; PARVOVIRUS;

EID: 33744732458     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1948     Document Type: Article

References (118)

1. Tsai, T. H., S. L. Chen, X. Xiao, Y. H. Chiang, S. Z. Lin, S. W. Kuo, D. W. Liu & Y. P. Tsao: Gene treatment of cerebral stroke by rAAV vector delivering IL-1ra in a rat model. Neuroreport, 14, 803-7 (2003)
2. Tsai, T. H., S. L. Chen, X. Xiao, D. W. Liu & Y. P. Tsao: Gene therapy for treatment of cerebral ischemia using defective recombinant adeno-associated virus vectors. Methods, 28, 253-8 (2002)
3. Bloom, D. C., N. T. Maidment, A. Tan, V. B. Dissette, L. T. Feldman & J. G. Stevens: Long-term expression of a reporter gene from latent herpes simplex virus in the rat hippocampus. Brain Res Mol Brain Res, 31, 48-60 (1995)
4. Byrnes, A. P., J. E. Rusby, M. J. Wood & H. M. Charlton: Adenovirus gene transfer causes inflammation in the brain. Neuroscience, 66, 1015-24 (1995)
5. Hallek, M. & C. M. Wendtner: Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: recent advances and potential clinical applications. Cytokines Mol Ther, 2, 69-79 (1996)
6. Akli, S., C. Caillaud, E. Vigne, L. D. Stratford-Perricaudet, L. Poenaru, M. Perricaudet, A. Kahn & M. R. Peschanski: Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet, 3, 224-8 (1993)
7. Prosch, S., J. Stein, K. Staak, C. Liebenthal, H. D. Volk & D. H. Kruger: Inactivation of the very strong HCMV immediate early promoter by DNA CpG methylation in vitro. Biol Chem Hoppe Seyler, 377, 195-201 (1996)
8. Pakzaban, P., A. I. Geller & O. Isacson: Effect of exogenous nerve growth factor on neurotoxicity of and neuronal gene delivery by a herpes simplex amplicon vector in the rat brain. Hum Gene Ther, 5, 987-95 (1994)
9. Le Gal La Salle, G., J. J. Robert, S. Berrard, V. Ridoux, L. D. Stratford-Perricaudet, M. Perricaudet & J. Mallet: An adenovinis vector for gene transfer into neurons and glia in the brain. Science, 259, 988-90 (1993)
10. Blacklow, N. R., M. D. Hoggan, A. Z. Kapikian, J. B. Austin & W. P. Rowe: Epidemiology of adenovirus-associated virus infection in a nursery population. Am J Epidemiol, 88, 368-78 (1968)
11. Keir, S. D., X. Xiao, J. Li & P. G. Kennedy: Adeno-associated virus-mediated delivery of glial cell line-derived neurotrophic factor protects motor neuron-like cells from apoptosis. J Neurovirol, 7, 437-46 (2001)
12. Zolotukhin, S., M. Potter, W. W. Hauswirth, J. Guy & N. Muzyczka: A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol, 70, 4646-54 (1996)
13. Afione, S. A., C. K. Conrad, W. G. Kearns, S. Chunduru, R. Adams, T. C. Reynolds, W. B. Guggino, G. R. Cutting, B. J. Carter & T. R. Flotte: In vivo model of adeno-associated virus vector persistence and rescue. J Virol, 70, 3235-41 (1996)
14. Flotte, T. R., S. A. Afione, C. Conrad, S. A. McGrath, R. Solow, H. Oka, P. L. Zeitlin, W. B. Guggino & B. J. Carter: Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci U S A, 90, 10613-7 (1993)
15. During, M. J., R. Xu, D. Young, M. G. Kaplitt, R. S. Sherwin & P. Leone: Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat Med, 4, 1131-5 (1998)
16. Alexander, I. E., D. W. Russell, A. M. Spence & A. D. Miller: Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum Gene Ther, 7, 841-50 (1996)
17. Doll, R. F., J. E. Crandall, C. A. Dyer, J. M. Aucoin & F. I. Smith: Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors. Gene Ther, 3, 437-47 (1996)
18. Mandel, R. J., R. O. Snyder & S. E. Leff: Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease. Exp Neurol, 160, 205-14 (1999)
19. Mochizuki, H., H. Hayakawa, M. Migita, M. Shibata, R. Tanaka, A. Suzuki, Y. Shimo-Nakanishi, T. Urabe, M. Yamada, K. Tamayose, T. Shimada, M. Miura & Y. Mizuno: An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease. Proc Natl Acad Sci U S A, 98, 10918-23 (2001)
20. Kaplitt, M. G., P. Leone, R. J. Samulski, X. Xiao, D. W. Pfaff, K. L. O'Malley & M. J. During: Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet, 8, 148-54 (1994)
21. McCown, T. J., X. Xiao, J. Li, G. R. Breese & R. J. Samulski: Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res, 713, 99-107 (1996)
22. McLaughlin, S. K., P. Collis, P. L. Hermonat & N. Muzyczka: Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol, 62, 1963-73 (1988)
23. Samulski, R. J., L. S. Chang & T. Shenk: Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol, 63, 3822-8 (1989)
24. Davidson, B. L., C. S. Stein, J. A. Heth, I. Martins, R. M. Kotin, T. A. Derksen, J. Zabner, A. Ghodsi & J. A. Chiorini: Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A, 97, 3428-32 (2000)
25. Tal, J.: Adeno-associated virus-based vectors in gene therapy. J Biomed Sci, 7, 279-91 (2000)
26. Xiao, X., J. Li & R. J. Samulski: Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol, 70, 8098-108 (1996)
27. Xiao, X., J. Li & R. J. Samulski: Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol, 72, 2224-32 (1998)
28. Tsai, T. H., S. L. Chen, Y. H. Chiang, S. Z. Lin, H. I. Ma, S. W. Kuo & Y. P. Tsao: Recombinant adeno-associated virus vector expressing glial cell line-derived neurotrophic factor reduces ischemia-induced damage. Exp Neurol, 166, 266-75 (2000)
29. Chen, S. T., C. Y. Hsu, E. L. Hogan, H. Maricq & J. D. Balentine: A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke, 17, 738-43 (1986)
30. Yanamoto, H., I. Nagata, Y. Niitsu, J. H. Xue, Z. Zhang & H. Kikuchi: Evaluation of MCAO stroke models in normotensive rats: standardized neocortical infarction by the 3VO technique. Exp Neurol, 182, 261-74 (2003)
31. Koizumi, J., Yoshida, Y., Nakazawa, T., Ooneda, G., 1986. Experimental studies of ischemic brain edema: a new experimental study of ischemic brain edema: 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn. J. stroke, 8, 1-8.
32. Longa, E. Z., P. R. Weinstein, S. Carlson & R. Cummins: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 20, 84-91 (1989)
33. Schmid-Elsaesser, R., S. Zausinger, E. Hungerhuber, A. Baethmann & H. J. Reulen: A critical reevaluation of the intraluminal thread model of focal cerebral ischemia: evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-Doppler flowmetry. Stroke, 29, 2162-70 (1998)
34. Menotti, A., D. R. Jacobs, Jr., H. Blackburn, D. Kromhout, A. Nissinen, S. Nedeljkovic, R. Buzina, I. Mohacek, F. Seccareccia, S. Giampaoli, A. Dontas, C. Aravanis & H. Toshima: Twenty-five-year prediction of stroke deaths in the seven countries study: the role of blood pressure and its changes. Stroke, 27, 381-7 (1996)
35. Rastenyte, D., J. Tuomilehto, S. Domarkiene, Z. Cepaitis & R. Reklaitiene: Risk factors for death from stroke in middle-aged Lithuanian men: results from a 20-year prospective study. Stroke, 27, 672-6 (1996)
36. Brown, R. D., J. P. Whisnant, J. D. Sicks, W. M. O'Fallon & D. O. Wiebers: Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke, 27, 373-80 (1996)
37. Hajimohammadreza, I., A. W. Probert, L. L. Coughenour, S. A. Borosky, F. W. Marcoux, P. A. Boxer & K. K. Wang: A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death. J Neurosci, 15, 4093-101 (1995)
38. Vornov, J. J.: Toxic NMDA-receptor activation occurs during recovery in a tissue culture model of ischemia. J Neurochem, 65, 1681-91 (1995)
39. Dalkara, T., C. Ayata, M. Demirci, G. Erdemli & R. Onur: Effects of cerebral ischemia on N-methyl-D-aspartate and dihydropyridine-sensitive calcium currents. An electrophysiological study in the rat hippocampus in situ. Stroke, 27, 127-33 (1996)
40. Strijbos, P. J., M. J. Leach & J. Garthwaite: Vicious cycle involving Na+ channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation. J Neurosci, 16, 5004-13 (1996)
41. Kim, G. W., T. Kondo, N. Noshita & P. H. Chan: Manganese superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia/reperfusion in mice: implications for the production and role of superoxide radicals. Stroke, 33, 809-15 (2002)
42. Yang, G. Y., L. Pang, H. L. Ge, M. Tan, W. Ye, X. H. Liu, F. P. Huang, D. C. Wu, X. M. Che, Y. Song, R. Wen & Y. Sun: Attenuation of ischemia-induced mouse brain injury by SAG, a redox-inducible antioxidant protein. J Cereb Blood Flow Metab, 21, 722-33 (2001)
43. Solenski, N. J., C. G. diPierro, P. A. Trimmer, A. L. Kwan & G. A. Helm: Ultrastructural changes of neuronal mitochondria after transient and permanent cerebral ischemia. Stroke, 33, 816-24 (2002)
44. Dettmers, C., A. Hartmann, T. Rommel, S. Kramer, S. Pappata, A. Young, S. Hartmann, S. Zierz, E. T. MacKenzie & J. C. Baron: Immersion and perfusion staining with 2,3,5-triphenyltetrazolium chloride (TTC) compared to mitochondrial enzymes 6 hours after MCA-occlusion in primates. Neurol Res, 16, 205-8 (1994)
45. Dimlich, R. V., M. J. Showers & M. T. Shipley: Densitometric analysis of cytochrome oxidase in ischemic rat brain. Brain Res, 516, 181-91 (1990)
46. Auer, R. N. & B. K. Siesjo: Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol, 24, 699-707 (1988)
47. Beal, M. F., K. J. Swartz, S. F. Finn, M. F. Mazurek & N. W. Kowall: Neurochemical characterization of excitotoxin lesions in the cerebral cortex. J Neurosci, 11, 147-58 (1991)
48. Malinski, T., F. Bailey, Z. G. Zhang & M. Chopp: Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab, 13, 355-8 (1993)
49. Kumura, E., H. Kosaka, T. Shiga, T. Yoshimine & T. Hayakawa: Elevation of plasma nitric oxide end products during focal cerebral ischemia and reperfusion in the rat. J Cereb Blood Flow Metab, 14, 487-91 (1994)
50. Sato, S., T. Tominaga, T. Ohnishi & S. T. Ohnishi: Role of nitric oxide in brain ischemia. Ann N Y Acad Sci, 738, 369-73 (1994)
51. Hamada, Y., T. Hayakawa, H. Hattori & H. Mikawa: Inhibitor of nitric oxide synthesis reduces hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res, 35, 10-4 (1994)
52. Zhang, Z. G., D. Reif, J. Macdonald, W. X. Tang, D. K. Kamp, R. J. Gentile, W. C. Shakespeare, R. J. Murray & M. Chopp: ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab, 16, 599-604 (1996)
53. del Zoppo, G., I. Ginis, J. M. Hallenbeck, C. Iadecola, X. Wang & G. Z. Feuerstein: Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol, 10, 95-112 (2000)
54. Feuerstein, G. Z., X. Wang & F. C. Barone: The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation, 5, 143-59 (1998)
55. Rothwell, N., S. Allan & S. Toulmond: The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest, 100, 2648-52 (1997)
56. Gillardon, F., C. Lenz, K. F. Waschke, S. Krajewski, J. C. Reed, M. Zimmermann & W. Kuschinsky: Altered expression of Bcl-2, Bcl-X, Bax, and c-Fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats. Brain Res Mol Brain Res, 40, 254-60 (1996)
57. Matsushita, K., T. Matsuyama, K. Kitagawa, M. Matsumoto, T. Yanagihara & M. Sugita: Alterations of Bcl-2 family proteins precede cytoskeletal proteolysis in the penumbra, but not in infarct centres following focal cerebral ischemia in mice. Neuroscience, 83, 439-48 (1998)
58. Isenmann, S., G. Stoll, M. Schroeter, S. Krajewski, J. C. Reed & M. Bahr: Differential regulation of Bax, Bcl-2, and Bcl-X proteins in focal cortical ischemia in the rat. Brain Pathol, 8, 49-62; discussion 62-3 (1998)
59. Asahi, M., M. Hoshimaru, Y. Uemura, T. Tokime, M. Kojima, T. Ohtsuka, N. Matsuura, T. Aoki, K. Shibahara & H. Kikuchi: Expression of interleukin-1 beta converting enzyme gene family and bcl-2 gene family in the rat brain following permanent occlusion of the middle cerebral artery. J Cereb Blood Flow Metab, 17, 11-8 (1997)
60. Chen, J., S. H. Graham, P. H. Chan, J. Lan, R. L. Zhou & R. P. Simon: bcl-2 is expressed in neurons that survive focal ischemia in the rat. Neuroreport, 6, 394-8 (1995)
61. Namura, S., J. Zhu, K. Fink, M. Endres, A. Srinivasan, K. J. Tomaselli, J. Yuan & M. A. Moskowitz: Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci, 18, 3659-68 (1998)
62. Fink, K., J. Zhu, S. Namura, M. Shimizu-Sasamata, M. Endres, J. Ma, T. Dalkara, J. Yuan & M. A. Moskowitz: Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation. J Cereb Blood Flow Metab, 18, 1071-6 (1998)
63. Klatzo, I.: Evolution of brain edema concepts. Acta Neurochir Suppl (Wien), 60, 3-6 (1994) 67.
64. Fishman, R. A.: Brain edema. N Engl J Med, 293, 706-11 (1975)
65. Verkman, A. S., A. N. van Hoek, T. Ma, A. Frigeri, W. R. Skach, A. Mitra, B. K. Tamarappoo & J. Farinas: Water transport across mammalian cell membranes. Am J Physiol, 270, C12-30 (1996)
66. King, L. S. & P. Agre: Pathophysiology of the aquaporin water channels. Annu Rev Physiol, 58, 619-48 (1996)
67. Trachtman, H.: Cell volume regulation: a review of cerebral adaptive mechanisms and implications for clinical treatment of osmolal disturbances: II. Pediatr Nephrol, 6, 104-12 (1992)
68. Hossmann, K. A.: Experimental models for the investigation of brain ischemia. Cardiovasc Res, 39, 106-20 (1998)
69. Kondo, T., A. G. Reaume, T. T. Huang, E. Carlson, K. Murakami, S. F. Chen, E.K. Hoffman, R. W. Scott, C. J. Epstein & P. H. Chan: Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci, 17, 4180-9 (1997)
70. Manley, G. T., M. Fujimura, T. Ma, N. Noshita, F. Filiz, A. W. Bollen, P. Chan & A. S. Verkman: Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med, 6, 159-63 (2000)
71. Hoehn, B., T. M. Ringer, L. Xu, R. G. Giffard, R. M. Sapolsky, G. K. Steinberg & M. A. Yenari: Overexpression of HSP72 after induction of experimental stroke protects neurons from ischemic damage. J Cereb Blood Flow Metab, 21, 1303-9 (2001)
72. Yenari, M. A., S. L. Fink, G. H. Sun, L. K. Chang, M. K. Patel, D. M. Kunis, D. Onley, D. Y. Ho, R. M. Sapolsky & G. K. Steinberg: Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann Neurol, 44, 584-91 (1998)
73. Reiter, R. J., R. M. Sainz, S. Lopez-Burillo, J. C. Mayo, L. C. Manchester & D. X. Tan: Melatonin ameliorates neurologic damage and neurophysiologic deficits in experimental models of stroke. Ann N Y Acad Sci, 993, 35-47; discussion 48-53 (2003)
74. Gunnett, C. A. & D. D. Heistad: The future of gene therapy for stroke. Curr Hypertens Rep, 3, 36-40 (2001)
75. Gupta, A., D. Y. Ho, S. Brooke, L. Franklin, M. Roy, J. McLaughlin, S. L. Fink & R. M. Sapolsky: Neuroprotective effects of an adenoviral vector expressing the glucose transporter: a detailed description of the mediating cellular events. Brain Res, 908, 49-57 (2001)
76. Ho, D. Y., T. C. Saydam, S. L. Fink, M. S. Lawrence & R. M. Sapolsky: Defective herpes simplex virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults. J Neurochem, 65, 842-50 (1995)
77. Yenari, M. A., M. Minami, G. H. Sun, T. J. Meier, D. M. Kunis, J. R. McLaughlin, D. Y. Ho, R. M. Sapolsky & G. K. Steinberg: Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia. Stroke, 32, 1028-35 (2001)
78. Touzani, O., H. Boutin, J. Chuquet & N. Rothwell: Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol, 100, 203-15 (1999)
79. Rothwell, N. J. & G. N. Luheshi: Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci, 23, 618-25 (2000)
80. Boutin, H., R. A. LeFeuvre, R. Horai, M. Asano, Y. Iwakura & N. J. Rothwell: Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci, 21, 5528-34 (2001)
81. Eisenberg, S. P., M. T. Brewer, E. Verderber, P. Heimdal, B. J. Brandhuber & R. C. Thompson: Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci U S A, 88, 5232-6 (1991)
82. Yang, G. Y., Y. J. Zhao, B. L. Davidson & A. L. Betz: Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury. Brain Res, 751, 181-8 (1997)
83. Yang, G. Y., X. H. Liu, C. Kadoya, Y. J. Zhao, Y. Mao, B. L. Davidson & A. L. Betz: Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. J Cereb Blood Flow Metab, 18, 840-7 (1998)
84. Yang, G. Y., Y. Mao, L. F. Zhou, C. Gong, H. L. Ge & A. L. Betz: Expression of intercellular adhesion molecule 1 (ICAM-1) is reduced in permanent focal cerebral ischemic mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. Brain Res Mol Brain Res, 65, 143-50 (1999)
85. Okada, Y., B. R. Copeland, E. Mori, M. M. Tung, W. S. Thomas & G. J. del Zoppo: P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke, 25, 202-11 (1994)
86. Wang, X., A. L. Siren, Y. Liu, T. L. Yue, F. C. Barone & G. Z. Feuerstein: Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex. Brain Res Mol Brain Res, 26, 61-8 (1994)
87. Wang, X., T. L. Yue, F. C. Barone & G. Z. Feuerstein: Demonstration of increased endothelial-leukocyte adhesion molecule-1 mRNA expression in rat ischemic cortex. Stroke, 26, 1665-8; discussion 1668-9 (1995)
88. Haring, H. P., B. S. Akamine, R. Habermann, J. A. Koziol & G. J. Del Zoppo: Distribution of integrin-like immunoreactivity on primate brain microvasculature. J Neuropathol Exp Neurol, 55, 236-45 (1996)
89. Chen, H., M. Chopp, R. L. Zhang, G. Bodzin, Q. Chen, J. R. Rusche & R. F. Todd, 3rd: Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann Neurol, 35, 458-63 (1994)
90. Zhang, R. L., M. Chopp, Y. Li, C. Zaloga, N. Jiang, M. L. Jones, M. Miyasaka & P. A. Ward: Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology, 44, 1747-51 (1994)
91. Zhang, R. L., Z. G. Zhang & M. Chopp: Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat. Neurology, 52, 273-9 (1999)
92. Lawrence, M. S., J. R. McLaughlin, G. H. Sun, D. Y. Ho, L. McIntosh, D. M. Kunis, R. M. Sapolsky & G. K. Steinberg: Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke. J Cereb Blood Flow Metab, 17, 740-4 (1997)
93. Roy, M., J. Hom & R. M. Sapolsky: Neuroprotection with herpes simplex vectors expressing virally derived anti-apoptotic agents. Brain Res, 901, 12-22 (2001)
94. Sun, Y., K. Jin, K. R. Clark, A. Peel, X. O. Mao, Q. Chang, R. P. Simon & D. A. Greenberg: Adeno-associated virus-mediated delivery of BCL-w gene improves outcome after transient focal cerebral ischemia. Gene Ther, 10, 115-22 (2003)
95. Lin, L. F., D. H. Doherty, J. D. Lile, S. Bektesh & F. Collins: GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science, 260, 1130-2 (1993)
96. Kitagawa, H., K. Abe, T. Hayashi, Y. Mitsumoto, N. Koga & Y. Itoyama: Ameliorative effect of glial cell line-derived neurotrophic factor on brain edema formation after permanent middle cerebral artery occlusion in rats. Neurol Res, 20, 333-6 (1998)
97. Kitagawa, H., T. Hayashi, Y. Mitsumoto, N. Koga, Y. Itoyama & K. Abe: Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. Stroke, 29, 1417-22 (1998)
98. Wang, Y., S. Z. Lin, A. L. Chiou, L. R. Williams & B. J. Hoffer: Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J Neurosci, 17, 4341-8 (1997)
99. Lin, T. N., P. Y. Wang, S. I. Chi & J. S. Kuo: Differential regulation of ciliary neurotrophic factor (CNTF) and CNTF receptor alpha (CNTFR alpha) expression following focal cerebral ischemia. Brain Res Mol Brain Res, 55, 71-80 (1998)
100. Hermann, D. M., E. Kilic, S. Kugler, S. Isenmann & M. Bahr: Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice. Neurobiol Dis, 8, 655-66 (2001)
101. Ay, H., I. Ay, W. J. Koroshetz & S. P. Finklestein: Potential usefulness of basic fibroblast growth factor as a treatment for stroke. Cerebrovasc Dis, 9, 131-5 (1999)
102. Hayashi, T., K. Abe & Y. Itoyama: Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab, 18, 887-95 (1998)
103. Shyu, W. C., S. Z. Lin, M. F. Chiang, H. I. Yang, P. Thajeb & H. Li: Neuregulin-1 reduces ischemia-induced brain damage in rats. Neurobiol Aging, 25, 935-44 (2004)
104. Duan, D., Y. Yue & J. F. Engelhardt: Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol Ther, 4, 383-91 (2001)
105. Goncalves, M. A., M. G. Pau, A. A. de Vries & D. Valerio: Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors. Virology, 288, 236-46 (2001)
106. Duan, D., Y. Yue, Z. Yan & J. F. Engelhardt: A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nat Med, 6, 595-8 (2000)
107. Clark, K. R.: Recent advances in recombinant adeno-associated virus vector production. Kidney Int, 61 Suppl 1, 9-15 (2002)
108. Qiao, C., J. Li, A. Skold, X. Zhang & X. Xiao: Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes. J Virol, 76, 1904-13 (2002)
109. Peng, K. W. & S. J. Russell: Viral vector targeting. Curr Opin Biotechnol, 10, 454-7 (1999)
110. Wickham, T. J.: Targeting adenovirus. Gene Ther, 7, 110-4 (2000)
111. Tebbutt, S. J.: Technology evaluation: AAV-CFTR vector, targeted genetics. Curr Opin Mol Ther, 1, 524-9 (1999)
112. Monahan, P. E. & R. J. Samulski: AAV vectors: is clinical success on the horizon? Gene Ther, 7, 24-30 (2000)
113. Isner, J. M.: Myocardial gene therapy. Nature, 415, 234-9 (2002)
114. Bellomo, M., E. B. Adamo, B. Deodato, M. A. Catania, C. Mannucci, H. Marini, M. C. Marciano, R. Marini, S. Sapienza, M. Giacca, A. P. Caputi, F. Squadrito & G. Calapai: Enhancement of expression of vascular endothelial growth factor after adeno-associated virus gene transfer is associated with improvement of brain ischemia injury in the gerbil. Pharmacol Res, 48, 309-17 (2003)
115. Khurana, R., J. F. Martin & I. Zachary: Gene therapy for cardiovascular disease: a case for cautious optimism. Hypertension, 38, 1210-6 (2001)
116. Morishita, R., G. H. Gibbons, K. E. Ellison, M. Nakajima, H. von der Leyen, L. Zhang, Y. Kaneda, T. Ogihara & V. J. Dzau: Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest, 93, 1458-64 (1994)
117. Arnold, T. E., D. Gnatenko & W. F. Bahou: In vivo gene transfer into rat arterial walls with novel adeno-associated virus vectors. J Vasc Surg, 25, 347-55 (1997)
118. Jiang, W., W. Gu, T. Brannstrom, R. Rosqvist & P. Wester: Cortical neurogenesis in adult rats after transient middle cerebral artery occlusion. Stroke, 32, 1201-7 (2001)